ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — MacroGenics Inc. (MGNX) on Tuesday reported third-quarter profit of $56.3 million.
On a per-share basis, the Rockville, Maryland-based company said it had profit of 90 cents.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 17 cents per share.
The biopharmaceutical company posted revenue of $110.7 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $97 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGNX at https://www.zacks.com/ap/MGNX
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.